» Articles » PMID: 22531786

A Transcriptional Repressor Co-regulatory Network Governing Androgen Response in Prostate Cancers

Overview
Journal EMBO J
Date 2012 Apr 26
PMID 22531786
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Transcriptional corepressors are frequently aberrantly over-expressed in prostate cancers. However, their crosstalk with the Androgen receptor (AR), a key player in prostate cancer development, is unclear. Using ChIP-Seq, we generated extensive global binding maps of AR, ERG, and commonly over-expressed transcriptional corepressors including HDAC1, HDAC2, HDAC3, and EZH2 in prostate cancer cells. Surprisingly, our results revealed that ERG, HDACs, and EZH2 are directly involved in androgen-regulated transcription and wired into an AR centric transcriptional network via a spectrum of distal enhancers and/or proximal promoters. Moreover, we showed that similar to ERG, these corepressors function to mediate repression of AR-induced transcription including cytoskeletal genes that promote epithelial differentiation and inhibit metastasis. Specifically, we demonstrated that the direct suppression of Vinculin expression by ERG, EZH2, and HDACs leads to enhanced invasiveness of prostate cancer cells. Taken together, our results highlight a novel mechanism by which, ERG working together with oncogenic corepressors including HDACs and the polycomb protein, EZH2, could impede epithelial differentiation and contribute to prostate cancer progression, through directly modulating the transcriptional output of AR.

Citing Articles

SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer.

Yan Y, Shi L, Ma T, Wang L, Huang H Biomolecules. 2025; 15(1).

PMID: 39858458 PMC: 11763896. DOI: 10.3390/biom15010064.


Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate.

Chen X, Augello M, Liu D, Lin K, Hakansson A, Sjostrom M Nat Commun. 2024; 15(1):10675.

PMID: 39672812 PMC: 11645413. DOI: 10.1038/s41467-024-53734-z.


Osteoblast-Derived ECM1 Promotes Anti-Androgen Resistance in Bone Metastatic Prostate Cancer.

Wang X, Wang M, Lin Q, He L, Zhang B, Chen X Adv Sci (Weinh). 2024; 12(2):e2407662.

PMID: 39563492 PMC: 11727142. DOI: 10.1002/advs.202407662.


Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer.

Cacciatore A, Shinde D, Musumeci C, Sandrini G, Guarrera L, Albino D Nat Commun. 2024; 15(1):6672.

PMID: 39107274 PMC: 11303763. DOI: 10.1038/s41467-024-50908-7.


Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications.

Lu B, Liu Y, Yao Y, Yang T, Zhang H, Yang X Front Oncol. 2024; 14:1355551.

PMID: 38800374 PMC: 11116611. DOI: 10.3389/fonc.2024.1355551.


References
1.
Zhu M, Kyprianou N . Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. FASEB J. 2009; 24(3):769-77. PMC: 2830130. DOI: 10.1096/fj.09-136994. View

2.
Heinlein C, Chang C . Androgen receptor in prostate cancer. Endocr Rev. 2004; 25(2):276-308. DOI: 10.1210/er.2002-0032. View

3.
Taylor B, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver B . Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22. PMC: 3198787. DOI: 10.1016/j.ccr.2010.05.026. View

4.
Zong Y, Xin L, Goldstein A, Lawson D, Teitell M, Witte O . ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc Natl Acad Sci U S A. 2009; 106(30):12465-70. PMC: 2708977. DOI: 10.1073/pnas.0905931106. View

5.
Min J, Zaslavsky A, Fedele G, McLaughlin S, Reczek E, De Raedt T . An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med. 2010; 16(3):286-94. PMC: 2903662. DOI: 10.1038/nm.2100. View